(Q33898576)

English

Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

14 September 2020

Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG). (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

12 November 2019

1 reference

12 November 2019

1 reference

14 September 2020

adjuvant chemotherapy

1 reference

PubMed publication ID

author name string

Diel IJ

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Mundy GR

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 April 2000

6 references

Europe PubMed Central

PubMed publication ID

29 July 2017

13 March 2019

3 April 2019

25 June 2019

12 November 2019

14 September 2020

British Journal of Cancer

6 references

Europe PubMed Central

PubMed publication ID

29 July 2017

13 March 2019

3 April 2019

25 June 2019

12 November 2019

14 September 2020

82

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1381-1386

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Molecular mechanisms of action of bisphosphonates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Bisphosphonates: mechanisms of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Bone and cancer: pathophysiology and treatment of metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

New bisphosphonates in the treatment of bone metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

The clinical course of bone metastases from breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat--benefit of combining bisphosphonates with cytostatic agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Bone metastases and breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Bone metastasis in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

5 July 2018

Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.1999.1077

21 January 2018

Mechanisms of osteolytic bone destruction

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.1999.1077

21 January 2018

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

29 October 2018

Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363374

29 October 2018

Effects of disodium etidronate in murine tumor models

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.1999.1077

21 January 2018

Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.1999.1077

21 January 2018

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of clodronate on breast cancer cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of new bisphosphonic acids on tumor-induced bone destruction in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopenia, hematopoiesis, and bone remodelling in iliac crest and femoral biopsies: a prospective study of 102 cases of femoral neck fractures

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hormone related protein and skeletal morbidity in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palliative pamidronate treatment in patients with bone metastases from breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate Cl2MBP

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of alendronate and taxol on PC-3 ML cell bone metastases in SCID mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/10780514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.1999.1077

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33898576&oldid=2195952675"